MARKET ACCESS
 

Market Access, 2019年3月19日(二)

08:45

Organiser’s welcome Remarks

Joe Zhou
08:50

Chair’s opening Remarks

Joe Zhou, Chief Executive Officer, Genor BioPharma, Walvax Group

Opening Keynote Plenary

David Lane
09:00

Going global and keeping it local: Is biotech innovation sustainable in Asia?

In this keynote presentation, Sir David Lane, one of the key scientists credited on the discovery of cancer gene p53, a gene which mutation cause near 50% of all human cancer, will share his view on how biomedical sciences have developed in Singapore, Japan and the remaining APAC region, and prospects for Asian biotech and pharma industry.
David Lane, Chief Scientist, Agency for Science, Technology and Research (A*STAR)
Byung-Geon Rhee
09:20

Looking east: Integrating Asia into the global era of innovative medicine

Byung-Geon Rhee, Chief Executive Officer, SCM Lifescience
Panel discussion
09:40

Pharma Trends: Women health as the next focus

Women’s health goes beyond mother & childcare. For instance, women has a higher risk of cardiovascular diseases compared to men, hence there is a need to invest more on addressing the biological differences in mainstream disease studies to ensure a more effective, personalised treatment. In addition, big data & AI application on female subjects may also differ from male subjects, prompting a need to investigate how studies should be developed differently in the future. This panel brings experts to debate and discuss how femtech is shaping to be the next global pharma focus and the new areas of focus in women's healthcare.
Moderator: Reenita Das, Partner, Frost & Sullivan
Evelyn Pang, Head Of Operations, Sanofi Pasteur
Marcel Van Duin, VP Research, Therapeutic Area Head, Reproductive Medicine & Women's Health, Ferring Pharmaceuticals
10:20

Speed networking & Networking Refreshment

PATIENT ACCESS

Access
11:15

Chair's opening remarks

Edmund Lim
Access
11:20

Starting from clinical phase: Patients involvement in building evidence and drug development (topic to be confirmed)

Edmund Lim, Co-Founder, We CARE Journey
Nathan Kothandaraman
Access
11:40

The role of industry in facilitating low to mid income countries to build capabilities and healthcare accessibility

Nathan Kothandaraman, Director, Market Access And Government Affairs, Janssen
Panel discussion
Access
12:00

Collaborative efforts in building the common ground for better accessibility and treatment

  • Key actions to bridge the gaps between stakeholders to provide for population in need
  • Models in helping advocacy group to coordinate for better access to treatment
  • Building the common ground in promoting better collaboration between advocacy groups, government, pharma and other stakeholders
Pratapa Satyanarayana, Former Senior Director And Group Country Head, Dr. Reddy?s Laboratories Ltd.
Enver Erkan, Country Manager, Pfizer
Gopal Rao, Global Business Development And Services Outsourcing, Biotech Division Lupin Ltd
Sook Yee Yap, Vice President, Malaysian Rare Disorders Society
Nadia Suttikulpanich, Head Of Fuchsia Innovation Center For Muang Thai Life Assurance, Muang Thai Life Assurance Public Company
12:40

Exhibition Visit & Networking Lunch

EVIDENCE BASED APPROACH

Access
14:10

Chair’s opening remarks

Philippe Pinton
Access
14:20

Maximizing RWE and PRO in Regulatory & reimbursement processes

Philippe Pinton, Regional Head, Specialty Therapy, Takeda
Jun Feng
Access
14:40

Making a value-outcome-based reimbursement model possible: How do we get there?

Jun Feng, Market Access Associate Director - Oncology, Japac, Abbvie
Panel discussion
Access
15:00

RWE as the basis of value-based reimbursement: Applications in APAC’s pharma industry

  • Overview of data-driven reimbursement process in APAC
  • Overcoming barriers to increase use of real world data
  • Improving quality of real world data
  • Standardising access and quality of RWE analytics
  • Working with payors and regulators on possible value based reimbursement model for innovative drugs and beyond
Moderator: Joseph Mocanu, Managing Director, Verge Capital Management
Gavin Teo, General Partner, B Capital Group
Bechara Saab, Chief Executive Officer and Chief Scientist, Mobio Interactive
15:40

Exhibition Visit & Networking Refreshments

VALUE & AFFORDABILITY

Susanne Weissbaecker
Access
16:40

Sustainable patient access model to oncology & innovative medicines: A case study

Susanne Weissbaecker, Global Head Of Access To Medicines, Takeda
Shailendra Bajpai
Access
17:00

Cost management & innovative pricing strategies in high value disease management (topic to be confirmed)

Shailendra Bajpai, Regional Medical Director, Sanofi-Aventis Singapore Pte Ltd
Dr Sushant Sahastrabuddhe
Access
17:20

Technology transfer and Product Development Partnerships (PDPs) in making vaccines affordable

Dr Sushant Sahastrabuddhe, Director, Enteric Fever, International Vaccine Institute
17:40

Networking Cocktail & End of Conference Day 1

last published: 17/Jan/19 09:15

 

* 活動內容有可能不事先告知作更動及調整。